Results 11 to 20 of about 5,533 (163)

Chinese expert consensus on the diagnosis and treatment of coronary microvascular diseases (2023 Edition)

open access: yesMedComm, Volume 4, Issue 6, December 2023., 2023
New recommendations and opinions released in Chinese expert consensus on the diagnosis and treatment of coronary microvascular diseases—2023, as compared with Chinese expert consensus on the diagnosis and treatment of coronary microvascular diseases issued in 2017. Abstract Since the four working groups of the Chinese Society of Cardiology issued first
Wenqiang Chen   +16 more
wiley   +1 more source

The Concise Guide to PHARMACOLOGY 2023/24: Catalytic receptors

open access: yesBritish Journal of Pharmacology, Volume 180, Issue S2, Page S241-S288, October 2023., 2023
The Concise Guide to PHARMACOLOGY 2023/24 is the sixth in this series of biennial publications. The Concise Guide provides concise overviews, mostly in tabular format, of the key properties of approximately 1800 drug targets, and nearly 6000 interactions with about 3900 ligands.
Stephen P. H. Alexander   +27 more
wiley   +1 more source

Viscoelastic testing: Critical appraisal of new methodologies and current literature

open access: yesInternational Journal of Laboratory Hematology, Volume 45, Issue 5, Page 643-658, October 2023., 2023
Abstract United States Food and Drug Administration (FDA)‐approved viscoelastic testing (VET) methodologies have significantly changed in the last 10 years, with the availability of cartridge‐based VET. Some of these cartridge‐based methodologies use harmonic resonance‐based clot detection.
Geoffrey D. Wool, Timothy Carll
wiley   +1 more source

Design and preclinical testing of an anti‐CD41 CAR T cell for the treatment of acute megakaryoblastic leukaemia

open access: yesJournal of Cellular and Molecular Medicine, Volume 27, Issue 19, Page 2864-2875, October 2023., 2023
Abstract Acute megakaryoblastic leukaemia (AMkL) is a rare subtype of acute myeloid leukaemia (AML) representing 5% of all reported cases, and frequently diagnosed in children with Down syndrome. Patients diagnosed with AMkL have low overall survival and have poor outcome to treatment, thus novel therapies such as CAR T cell therapy could represent an ...
Adrian Bogdan Tigu   +22 more
wiley   +1 more source

Shear‐Responsive Drug Delivery Systems in Medical Devices: Focus on Thrombosis and Bleeding

open access: yesAdvanced Functional Materials, Volume 33, Issue 37, September 12, 2023., 2023
This review explores the risk of thrombus formation in blood‐contacting medical devices, and the use of antithrombotic drugs to reduce the risk while balancing the risk of bleeding complications. The potential of the shear‐responsive nanomedicine‐based drug delivery systems for targeted antithrombotic therapy is investigated.
Saeedreza Zeibi Shirejini   +4 more
wiley   +1 more source

Bilateral subconjunctival hemorrhage secondary to abciximab use: case report

open access: yesSão Paulo Medical Journal, 2017
CONTEXT: There are no reports on cases of subconjunctival hemorrhage due to use of glycoprotein IIb/IIIa inhibitors. In this report, we present the case of a patient with bilateral subconjunctival hemorrhage after receiving abciximab.
Selim Kul, Muhammet Raşit Sayın
doaj   +1 more source

Effects of abciximab on key pattern of human coronary restenosis in vitro: impact of the SI/MPL-ratio

open access: yesBMC Cardiovascular Disorders, 2006
Background The significant reduction of angiographic restenosis rates in the ISAR-SWEET study (intracoronary stenting and antithrombotic regimen: is abciximab a superior way to eliminate elevated thrombotic risk in diabetes) raises the question of ...
Baur Regine   +4 more
doaj   +1 more source

Efficacy and safety of abciximab versus tirofiban in addition to ticagrelor in STEMI patients undergoing primary percutaneous intervention

open access: yesPlatelets, 2022
Platelet glycoprotein IIb/IIIa inhibitors (GPIs) have been part of the adjuvant treatment of acute coronary syndrome for years. However, real-life data regarding the efficacy and safety of GPIs under the current indications are lacking in the setting of ...
Pablo Revilla-Martí   +8 more
doaj   +1 more source

Intracoronary versus intravenous abciximab in ST-segment elevation myocardial infarction: rationale and design of the CICERO trial in patients undergoing primary percutaneous coronary intervention with thrombus aspiration

open access: yesTrials, 2009
Background Administration of abciximab during primary percutaneous coronary intervention is an effective adjunctive therapy in the treatment of patients with ST-segment elevation myocardial infarction.
Gu Youlan L   +6 more
doaj   +1 more source

FLOW DIVERTER DEVICE IN THE ACUTE SETTING OF RUPTURED BLISTER LIKE ANEURYSM: A CASE REPORT [PDF]

open access: yesEuromediterranean Biomedical Journal, 2021
Blister-like aneurysms (BLA) are a rare half-dome-shaped aneurysm, with a broad-based appearance, originating more often from a non-branching site of the supraclinoid internal carotid artery (ICA).
Cesare Gaglaiardo
doaj   +1 more source

Home - About - Disclaimer - Privacy